Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

993 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group.
Sweetenham JW, Santini G, Qian W, Guelfi M, Schmitz N, Simnett S, Nagler A, Holte H, Kvaloy S, Bruzzi P, Goldstone AH. Sweetenham JW, et al. Among authors: schmitz n. J Clin Oncol. 2001 Jun 1;19(11):2927-36. doi: 10.1200/JCO.2001.19.11.2927. J Clin Oncol. 2001. PMID: 11387366 Clinical Trial.
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
Smith TJ, Hillner BE, Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Link H, Zander A, Yanovich S, Kitchin R, Erder MH. Smith TJ, et al. Among authors: schmitz n. J Clin Oncol. 1997 Jan;15(1):5-10. doi: 10.1200/JCO.1997.15.1.5. J Clin Oncol. 1997. PMID: 8996118 Clinical Trial.
High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party.
Sweetenham JW, Carella AM, Taghipour G, Cunningham D, Marcus R, Della Volpe A, Linch DC, Schmitz N, Goldstone AH. Sweetenham JW, et al. Among authors: schmitz n. J Clin Oncol. 1999 Oct;17(10):3101-9. doi: 10.1200/JCO.1999.17.10.3101. J Clin Oncol. 1999. PMID: 10506605
High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry.
Williams CD, Harrison CN, Lister TA, Norton AJ, Blystad AK, Coiffier B, Taghipour G, Schmitz N, Goldstone AH; European Bone Marrow Transplant Lymphoma Working Party. Williams CD, et al. Among authors: schmitz n. J Clin Oncol. 2001 Feb 1;19(3):727-35. doi: 10.1200/JCO.2001.19.3.727. J Clin Oncol. 2001. PMID: 11157024 Clinical Trial.
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ, Ruiz de Elvira MC, Taghipour G, Cordonnier C, Gluckman E, de Witte T, Santini G, Blaise D, Greinix H, Ferrant A, Cornelissen J, Schmitz N, Goldstone AH; European Bone Marrow Transplantation (EBMT) Lymphoma Registry. Peniket AJ, et al. Among authors: schmitz n. Bone Marrow Transplant. 2003 Apr;31(8):667-78. doi: 10.1038/sj.bmt.1703891. Bone Marrow Transplant. 2003. PMID: 12692607
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study.
Montoto S, Canals C, Rohatiner AZ, Taghipour G, Sureda A, Schmitz N, Gisselbrecht C, Fouillard L, Milpied N, Haioun C, Slavin S, Conde E, Fruchart C, Ferrant A, Leblond V, Tilly H, Lister TA, Goldstone AH; EBMT Lymphoma Working Party. Montoto S, et al. Among authors: schmitz n. Leukemia. 2007 Nov;21(11):2324-31. doi: 10.1038/sj.leu.2404850. Epub 2007 Jul 19. Leukemia. 2007. PMID: 17637813
Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation.
Milligan DW, Ruiz De Elvira MC, Kolb HJ, Goldstone AH, Meloni G, Rohatiner AZ, Colombat P, Schmitz N. Milligan DW, et al. Among authors: schmitz n. Br J Haematol. 1999 Sep;106(4):1020-6. doi: 10.1046/j.1365-2141.1999.01627.x. Br J Haematol. 1999. PMID: 10520006 Free article.
Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftment.
Kottaridis PD, Peggs K, Schmitz N, Dreger P, Boogaerts MA, Ferrant A, Demuynck HM, Zander A, Link H, Matcham J, Linch DC, Borkett K, Goldstone AH. Kottaridis PD, et al. Among authors: schmitz n. Leuk Lymphoma. 2002 Mar;43(3):531-6. doi: 10.1080/10428190290012010. Leuk Lymphoma. 2002. PMID: 12002756 Clinical Trial.
Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.
Pettengell R, Uddin R, Boumendil A, Johnson R, Metzner B, Martín A, Romejko-Jarosinska J, Bence-Bruckler I, Giri P, Niemann CU, Robinson SP, Kimby E, Schmitz N, Dreger P, Goldstone AH, Montoto S. Pettengell R, et al. Among authors: schmitz n. Bone Marrow Transplant. 2021 Jun;56(6):1413-1421. doi: 10.1038/s41409-020-01182-w. Epub 2021 Jan 15. Bone Marrow Transplant. 2021. PMID: 33452448 Clinical Trial.
993 results